HAM
EGRX

Highstreet Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Highstreet Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
53
– – ﹤0.01% 576
2019
Q3 		$3K Buy
53
+15
+39% +$844 ﹤0.01% 343
2019
Q2 		$2K Hold
38
– – ﹤0.01% 375
2019
Q1 		$2K Hold
38
– – ﹤0.01% 382
2018
Q4 		$2K Hold
38
– – ﹤0.01% 371
2018
Q3 		$3K Buy
+38
New +$2.88K ﹤0.01% 355

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Highstreet Asset Management's EGRX Position: Q4 2019 in Review

Highstreet Asset Management held its Eagle Pharmaceuticals, Inc. (EGRX) position steady in Q4 2019 at 53 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Highstreet Asset Management first reported a position in EGRX in Q3 2018 and has held it in 6 quarters since. 176 funds tracked by Wall St. Rank hold EGRX as of Q4 2019.

  • Highstreet Asset Management held 53 shares of Eagle Pharmaceuticals, Inc. worth $3K as of Q4 2019.
  • Highstreet Asset Management left its Eagle Pharmaceuticals, Inc. share count unchanged in Q4 2019.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Highstreet Asset Management's portfolio in Q4 2019, its #576 holding.
  • Highstreet Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2018 and has held it in 6 quarters since.
  • 176 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.